$ImmPACT Bio Announces FDA Clearance of IND Application for Bispecific CD19/CD20 CAR T Therapy IMPT-514 for the Treatment of Refractory Systemic Lupus Erythematosus$

Guest User 8/16/23 Guest User 8/16/23

ImmPACT Bio Announces FDA Clearance of IND Application for Bispecific CD19/CD20 CAR T Therapy IMPT-514 for the Treatment of Refractory Systemic Lupus Erythematosus

Guest User 8/10/23 Guest User 8/10/23

GEN: Top 10 U.S. Biopharma Clusters

Guest User 8/9/23 Guest User 8/9/23

Phase 1 clinical trial underway to test City of Hope-developed cancer treatment

Guest User 8/3/23 Guest User 8/3/23

Reflections and Takeaways from our Second Annual Greater Los Angeles Life Science Forum

Guest User 8/2/23 Guest User 8/2/23

Reed Jobs, son of Steve Jobs, takes the wraps off a $200 million venture fund that will back new cancer treatments

Guest User 8/2/23 Guest User 8/2/23

Biocom California Appoints Dan Gober as Executive Director of its Los Angeles Office

Guest User 8/1/23 Guest User 8/1/23

Life science entrepreneur Leen Kawas’s tips for what it takes for startups to thrive in 2023

Guest User 8/1/23 Guest User 8/1/23

Construction underway for Harbor-UCLA Medical Center's new clinic building

Guest User 7/31/23 Guest User 7/31/23

ARPA-H launches program for more precise cancer tumor removal

Guest User 7/31/23 Guest User 7/31/23

Will Irvine become the nation’s next healthcare hub?